Prognostic value of EASIX, m-EASIX, and systemic inflammatory markers in pediatric classical Hodgkin lymphoma: a single-center cohort study
The endothelial activation and stress index (EASIX = lactate dehydrogenase × creatinine/platelets) and its modified form (m-EASIX, using C-reactive protein instead of creatinine) are associated with outcome in several adult hematologic malignancies, including classical Hodgkin lymphoma (cHL). Their value in children—whose serum creatinine is strongly age-dependent—is unknown. We retrospectively analyzed 71 patients (aged 3–17 years at diagnosis; eligibility 0–18 years) with cHL treated between 2019 and 2026 to determine whether diagnostic EASIX and m-EASIX are associated with progression-free survival (PFS). EASIX, m-EASIX, and routine inflammatory indices (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio, systemic immune-inflammation index [SII], HALP, prognostic nutritional index) were calculated at diagnosis. EASIX and m-EASIX were analyzed primarily as continuous log2-transformed variables using Cox regression (hazard ratios expressed per doubling), with discrimination assessed by Harrell’s C-index and time-dependent ROC; the published adult m-EASIX threshold and an exploratory age-normalized EASIX were additionally tested. At a median follow-up of 40 months, 20 PFS events occurred; 3-year PFS and overall survival were 73.6% and 96.5%. Neither log2(EASIX) (hazard ratio [HR] per doubling 1.03, 95% CI 0.66–1.63; p=0.890) nor log2(m-EASIX) (HR per doubling 1.08, 95% CI 0.92–1.27; p=0.362) was significantly associated with PFS, and both showed limited discrimination (C-index 0.525 [95% CI 0.465–0.677] and 0.542 [95% CI 0.459–0.674]). Only 2 of 71 patients exceeded the adult DLBCL-derived EASIX threshold of 1.33, whereas 47 of 71 exceeded the adult cHL m-EASIX threshold of 17.28, which did not stratify PFS (log-rank p=0.92); an exploratory age-normalized EASIX remained non-discriminatory. In contrast, advanced stage (univariate HR 3.58, 95% CI 1.19–10.76; p=0.023) and slow early response (univariate HR 3.16, 95% CI 1.19–8.44; p=0.021) were associated with shorter PFS, as were NLR (HR 1.13 per unit, 95% CI 1.02–1.24; p=0.016) and SII (HR 1.25 per 1000 units, 95% CI 1.06–1.47; p=0.007) in secondary, exploratory analyses, although all of these associations attenuated to borderline significance after correction for multiple testing (Benjamini–Hochberg-adjusted p≈0.10). The Childhood Hodgkin International Prognostic Score was not significantly associated with PFS (HR 1.29 per point, 95% CI 0.79–2.13; p=0.312). In this single-center pediatric cHL cohort, diagnostic EASIX and m-EASIX showed limited prognostic discrimination; the adult cHL m-EASIX threshold did not stratify PFS, and almost no patient reached the adult DLBCL-derived EASIX threshold. Disease stage and early treatment response were associated with PFS, and NLR and SII showed exploratory associations; all of these findings require validation in larger pediatric cohorts.
Authors
- Derya Özyörük (ORCID: https://orcid.org/0000-0002-9615-6522)
- Arzu Yazal Erdem (ORCID: https://orcid.org/0000-0003-1043-8471)
- Emre Sefa GÜLTEKIN
- F. Burçin Kurtipek
- Selma Çakmakçı
- Neriman Sarı
Institutions
- Ankara Yıldırım Beyazıt University (TR)
- Ankara Bilkent City Hospital (TR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-11-20
- DOI
- https://doi.org/10.3389/fonc.2026.2001401
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00